Bacillus anthracis Lethal Toxin Disrupts TCR Signaling in CD1d-Restricted NKT Cells Leading to Functional Anergy by Joshi, Sunil K. et al.
Bacillus anthracis Lethal Toxin Disrupts TCR Signaling in
CD1d-Restricted NKT Cells Leading to Functional Anergy
Sunil K. Joshi
., Gillian A. Lang
., Jason L. Larabee, T. Scott Devera, Lindsay M. Aye, Hemangi B. Shah,
Jimmy D. Ballard, Mark L. Lang*
Department of Microbiology and Immunology, University of Oklahoma Health Sciences Center, Oklahoma City, Oklahoma, United States of America
Abstract
Exogenous CD1d-binding glycolipid (a-Galactosylceramide, a-GC) stimulates TCR signaling and activation of type-1 natural
killer–like T (NKT) cells. Activated NKT cells play a central role in the regulation of adaptive and protective immune responses
against pathogens and tumors. In the present study, we tested the effect of Bacillus anthracis lethal toxin (LT) on NKT cells
both in vivo and in vitro. LT is a binary toxin known to suppress host immune responses during anthrax disease and
intoxicates cells by protective antigen (PA)-mediated intracellular delivery of lethal factor (LF), a potent metalloprotease. We
observed that NKT cells expressed anthrax toxin receptors (CMG-2 and TEM-8) and bound more PA than other immune cell
types. A sub-lethal dose of LT administered in vivo in C57BL/6 mice decreased expression of the activation receptor NKG2D
by NKT cells but not by NK cells. The in vivo administration of LT led to decreased TCR-induced cytokine secretion but did
not affect TCR expression. Further analysis revealed LT-dependent inhibition of TCR-stimulated MAP kinase signaling in NKT
cells attributable to LT cleavage of the MAP kinase kinase MEK-2. We propose that Bacillus anthracis–derived LT causes a
novel form of functional anergy in NKT cells and therefore has potential for contributing to immune evasion by the
pathogen.
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Introduction
CD1d-restricted Type I NKT cells are central regulators of
adaptive immune responses [1]. NKT cells can be activated with
exogenous CD1d-binding glycolipid antigen (Ag) to boost humoral
immunity and prime CTL responses specific for co-administered
Ag [2,3,4]. The mechanisms by which NKT cells enhance
antibody (Ab) responses are unclear but involve cognate and
non-cognate interactions between NKT cells and B cells [5,6,7].
The interactions of dendritic cells (DC) and NKT cells have been
studied more extensively. NKT cells can drive DC maturation and
induction of tumor-specific CTL [8,9], a mechanism likely
important for NKT-enhanced tumor rejection [4,10]. There is
also evidence for increased priming of Th responses as a result of
NKT activation suggesting an important contribution to the
initiation of adaptive immunity [4].
NKT cells contribute to the adaptive (and protective) immune
response to bacterial, viral and potentially parasitic infections
[11,12,13]. However, the effects of pathogen-derived virulence
factors including bacterial exotoxins on NKT function have
received little attention. The Bovine Calmette-Guerin (BCG)
bacterium, bacterial LPS and CD1d-binding glycolipids can
induce a state of non-responsiveness or anergy in NKT cells
although it is not appreciated whether this is reflective of
pathogen-derived products subverting the host immune response
and/or the host limiting the production of tissue-damaging NKT
products following infection [14,15].
Bacillus anthracis lethal toxin (LT) is a paradigm for virulence
factors that strongly subvert and suppress host immunity during
disease [16,17,18]. Anthrax involves severe and extensive
bacteremia with the organism growing to very high numbers
(.10
8 organisms/ml) in the bloodstream. This high level of
growth is thought to be possible because LT severely cripples the
host immune system. Thus, the mechanism by which LT
intoxicates cells has been the subject of intense study. In order
to disrupt target-cell function, protective antigen (PA) interacts
with specific cell surface receptors, forms a heptameric structure
that is bound by LF, and the complex is endocytosed into the
cytosol [19]. Once delivered by PA into the cell, LF cleaves and
inactivates MAPKKs, such as MEK-2, leading to disruption in
MAPK signaling [20]. Yet, despite these many important
advances in understanding the mechanism of cellular intoxication
by LT, little is known about the specific types of immune cells
targeted by this toxin during disease.
In the present study, we tested the hypothesis that a sub-lethal
dose of LT administered in vivo could impact murine NKT cell
function. We report that NKT cells express anthrax toxin
receptors and bind PA to a greater degree than other types of
immune cell. LT also causes reduced expression of several
activation-inducing molecules on NKT cells. Furthermore, LT
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plexes as evidenced by reduced cytokine secretion. These results
indicate that one of the immune evasion/suppression strategies
employed by B. anthracis involves reduced NKT activation.
Materials and Methods
Toxin expression and purification
Histidine-tagged PA and LF were expressed separately in
competent BL21 Escherichia coli (Invitrogen, Carlsbad, CA) trans-
formed with the pET15b-rPA, pET15b-rLF and pET15brLF
H690C
plasmids respectively (gifts from Dr. J. Collier, Harvard Medical
School). PA and LF were then purified from bacterial lysates using
standard methods also described previously [21]. In brief, PA and
LF purification was achieved using a 5 ml HisTrap FF affinity
column (GE LifeSciences, Piscataway, NJ). LPS contamination was
removed by from purified PA and LF using an EndoTrap Red LPS-
binding affinity column (Lonza, Walkersville, MD). The concen-
tration of residual endotoxin was determined using the Limulus
Assay, which has a sensitivity of 0.06 Endotoxin Units/ml (6 pg/ml)
(Lonza). The final preparation used for this study contained
40 ng/ml LPS in the PA and was below the limits of detection for
the LF. No more than 4 ng LPS was administered to each mouse
in experiments described herein.
Mice
Female C57BL/6 mice were purchased from the National
Cancer Institute (Bethesda, MD) and used for experiments at 6–
10 wk of age. Ja18
2/2 mice (also known as Ja281
2/2) on the
C57BL/6 genetic background were obtained from Dr. M.
Kronenberg (La Jolla Institute for Allergy and Immunology) with
kind permission from Dr M. Taniguchi (RIKEN Institute, Japan).
The Institutional Animal Care and Use Committee at the
University of Oklahoma Health Sciences Center approved all
procedures described herein.
Toxin administration
200 mg of lethal toxin (1:1 molar ratio of PA and LF) in sterile
endotoxin-free PBS was administered i.v. by para-orbital injection
whilst mice were anesthetized using 4% vaporized isofluorane.
Mice were euthanized 4 days after toxin injection. Spleen, liver,
thymus and LN were harvested.
Cell isolation
Single cell suspensions were prepared from the harvested tissue
by mechanical disruption. Erythrocytes were removed by lysis with
ammonium chloride buffer (0.16 M NH4Cl, 0.17 M Tris- HCl,
pH 7.4). Cells were washed in RPMI 1640 and cell number and
viability were assessed by trypan blue exclusion. Hepatic
lymphocytes were obtained from hepatocytes by percoll density
gradient centrifugation.
Antibodies and fluorochromes
Allophycocyanin (APC-) or PE-conjugated CD1d tetramer
loaded with a-GC was obtained from the NIAID tetramer facility
(Emory University, Atlanta, GA). 2.4G2 Fc-blocking mAb was
purchased from BioXcell (Lebanon, NH). Anti-CD49b, -CD3,
-CD28 and -TCRb mAbs were purchased from BD Biosciences
(Palo Alto, CA). Anti-Erk1/2 and anti-phospho-Erk1/2 polyclonal
Abs were purchased from Cell Signaling Technology (Worcester,
MA). Anti-MEK-2 N-terminal polyclonal Ab was purchased from
Santa Cruz Biotechnology (Santa Cruz, CA). Anti-GAPDH mAb
was purchased from Abcam Inc. (Cambridge, MA). All other
antibodies were from e-Bioscience (San Diego, CA). Alexa
647-conjugated PA was produced in house using an Alexa
labeling kit according to manufacturer’s instructions (Invitrogen,
Carlsbad, CA).
Flow cytometry
The 2.4G2 mAb was added to cell suspensions at a final
concentration of 20 mg/ml. Cells were then incubated at room
temperature for 1 h with a 1:250 dilution of CD1d tetramer and
appropriate mAbs at a 1:100 2200 dilution. Unbound mAbs and
tetramer were removed by washing cells three times in PBS. Cells
were fixed with 1% v/v p-formaldehyde in PBS and samples were
then analyzed by flow cytometry (FACSCalibur, Becton Dick-
inson, Palo Alto, CA.).
In vitro NKT stimulation
Four similar approaches were taken to stimulate NKT cell TCR
signaling. (i) Splenocytes were obtained from mice treated with LT
in vivo. Splenocytes were then stimulated in vitro with a-GC
(BioMol, Cambridge, MA) at a final concentration of 50 ng/ml.
After 24 and 48 h, supernatants were collected and stored at
280uC. (ii) Splenocytes were obtained from NKT-deficient
Ja18
2/2 mice and in vitro-expanded NKT cells were obtained
from splenocytes of C57BL/6 mice using a modified version of the
method reported by the Taniguchi laboratory [22]. NKT cell
purity as defined by CD1d tetramer binding was 85%–96% in the
experiments reported herein. Ja18
2/2 splenocytes and C57BL/6
NKT cells were treated for 1 h with PBS or LT at a final
concentration of 1 mg/ml. After washing the PBS-treated and LT-
treated cells were cultured separately or co-cultured (splenocytes
plus NKT cells) in the absence or presence of a-GC at a final
concentration of 50 ng/ml for 48 h. The supernatants were then
collected and stored at 280uC until required. IL-4 and IFNc
concentrations in the supernatants were then determined by
Multi-Plex cytokine analysis according to manufacturer’s instruc-
tions using the Bio-Plex assay system (Bio-Rad, Hercules, CA). (iii)
Anti-NK1.1-enriched NKT cells (52% pure) were treated with
PBS or LT in vitro and then cultured on 96 well plates coated with
anti-CD3 mAb at a coating concentration of 10 mg/ml and with
media containing 10 mg/ml anti-CD28 mAb. After 48 h, cell
culture supernatants were collected for analysis. In these assays,
the remaining cells were tetramer
2/TCR
+/NK1.1
+ cells, NK cells
and there were no detectable T cells (iv) Anti-NK1.1-enriched
Author Summary
The bacterium Bacillus anthracis is the causative agent of
anthrax infection. Anthrax is a life-threatening disease
caused by inhalation or ingestion of spores, or transmission
through wounds and abrasions. The bacterium secretes
toxins, proteins that enter numerous cell types in an
infected individual altering their function and contributing
to the disease process. Consequently, we and other
researchers are dedicated to identifying cells affected by
anthrax toxins and to understanding the implications for
the function of those cells. We have observed that anthrax
toxins adversely affect a type of cell in the immune system
known as a natural killer–like T (NKT) cell. NKT cells are
found in the bone marrow, blood, spleen, lymph nodes and
liver and are required for optimal immune responses. We
report that anthrax toxins effectively shut down NKT cells,
preventing them from functioning normally. We propose
that this has serious consequences because anyone
infected with Bacillus anthracis will be less able to mount
an immune response against it.
Anthrax Toxins Inhibit NKT Function
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CD3 mAb at 4uC before washing and cross-linking the bound Ab
by addition of an anti-Armenian Hamster IgG solution (Rockland
Inc., Rockland, MD) at 37uC. After 5 minutes cells were pelleted
by a 7 s micro-centrifuge pulse. Pellets were immediately re-
suspended in ice-cold lysis buffer containing: 1.0% v/v NP40; a
protease inhibitor cocktail (Roche Systems Inc., Pleasanton,
California); 4.0 mM Na3VO4 and 2.0 mM NaF. After incubation
on ice for 30 min, lysates were then clarified by centrifugation at
13,000 RCF for 10 min at 4uC. Supernatants were collected and
stored at 220uC until required.
Immunoblot
Cell lysates were subjected to SDS-PAGE under reducing
conditions and proteins were then transferred to nitrocellulose
membranes using a Bio-Rad semi-dry blotter. Membranes were
blocked with 5% w/v non-fat dry milk in PBS containing 0.5% v/v
TWEEN-20for1 hbeforeadditionofprimaryAbata1 mg/mlfinal
concentration and incubation overnight at 4uC. Membranes were
washed 6 times in PBS before incubation with HRP-conjugated
secondary Ab in 3% milk in PBS containing 0.05% v/v TWEEN-20
and further washing. ECL Plus reagent (GE Healthcare, Piscataway,
NJ) was used to detect membrane-bound Ab and imaged using
Blue Basic Autoradiography Film (ISC BioExpress, Kaysville,
UT).
Results
Protective antigen targets NKT cells
Hepatic lymphocytes, splenocytes, lymph node cells and
thymocytes were obtained from C57BL/6 mice. The cells were
stained with a-GC-loaded CD1d-tetramer and anti-TCRb mAb
to distinguish between type I NKT cells (a-GC/CD1d tetramer
+/
TCRb
+), T cells (a-GC/CD1d tetramer
2/TCRb
+) and non-
NKT/T cells (a-GC/CD1d tetramer
2/TCRb
2) and counter-
stained with Alexa647-conjugated PA (Figure 1A). We observed
that PA bound all a-GC/tetramer/TCRb
+ cells and did so to a
greater extent than TCRb
+ T cells and non-T/NKT cells
represented mainly by B cells and dendritic cells. The binding of
PA to all cells could be saturated and then competed out with a 10-
fold molar excess of unlabeled PA indicating expression of specific
receptors (Figure 1B). The Kd for binding of PA to NKT cells was
approximately 20 nM which is consistent with the observed
expression of both known PA receptors Tumor Endothelial
Marker-8 (TEM-8) and Capillary Morphogenesis protein-2
(CMG-2) with reported affinities in vitro of 130 nM and 0.17 nM
respectively [23]. Purified splenic NKT cells were shown by
immunoblot to express the 60 kDa and 45 kDa splice variants of
TEM-8 and the 55 kDa form of CMG-2 (Figure 1C) at a greater
abundance, relative to splenocyte lysates. The stronger signal
obtained with the NKT lysates as compared to the splenic lysates is
consistent with the differential expression detected by flow
cytometry. These data show that NKT cells express higher
amounts of the PA receptors than other hematopoietic cell types,
suggesting NKT cells may be more susceptible to the effects of LT
than other cell types.
Lethal toxin alters expression of several NKT cell surface
markers
C57BL/6 mice were treated with a sub-lethal dose of LT and
splenocytes were harvested 4 d later (Figure 2). We observed that
LT treatment had no effect on binding of a-GC/CD1d tetramers
or anti-TCRb mAb, indicating that expression of the invariant
Va14/Ja18 TCR was not affected by LT. Similarly, TCRb
expression on T cells was not affected (Figure 2A). LT induced
considerable splenomegaly increasing the total cellular yield
approximately two fold but had only a small effect on the
frequency (25% increase) of NKT cells in the spleen (Figure S1).
The increase in splenic NKT cell numbers could be caused by
recruitment from other locations, proliferation of splenic NKT
cells or a combination of both effects.
Several NK- and NKT-associated activating and inhibitory
receptors as well as other markers of NKT activation were then
examined (Figure 2B). LT treatment resulted in decreased
expression of the activation molecule NKG2d but had no effect
on NK1.1 expression. The effect on NKG2D expression was
specific to NKT cells since toxin did not alter NKG2D expression
by NK cells in C57Bl/6 or Ja18
2/2 mice (Figure S2A).
Furthermore, active LT was required since a function-deficient
mutant LT
H690C did not affect NKG2D expression by NKT cells
(Figure S2B). A minor increase in the expression of the inhibitory
LY49 receptors was observed following treatment with active LT
(Figure 2B). There was also a small increase in the expression of
CD62L and a substantial decrease in the expression of CD69
(Figure 2B). NKT cells have an innate ‘memory/activated
phenotype’ and unlike naı ¨ve T cells (CD69
lo/CD62L
hi) are
constitutively CD69
hiCD62L
lo [24]. Changes in NKG2D expres-
sion by splenic NKT cells were not observed 3 h, 6 h and 14 d
after LT in vivo administration (Figure S3A). In contrast, although
splenocytes had returned to the pre-treatment phenotype by 14 d,
LN cells still had reduced NKG2D expression (Figure S3B).
Thymic NKT cells were also largely NKG2D
+ indicating that the
primary target of the toxin was NKT cells in the periphery rather
than developing NKT cells in the thymus (Figure S3C). We also
tested the effect of the toxin components PA and LF individually
and did not observe splenomegaly, changes in NKT frequency,
tetramer binding, or expression of TCRb and NKG2D (data not
shown). In further controls we determined that 20 ng, and 4 mgo f
LPS administered by the i.v. route did not result in reduced
NKG2D or CD69 expression by NKT cells at 96 h as observed
for LT (data not shown). This demonstrates that any residual LPS
(estimated at no more than 4 ng per dose) in the LT preparation
does not account for the observed effects of LT on NKT cells.
The overall effect of LT treatment therefore appears to be a
shift from the memory/activated phenotype to that of an anergic
NKT cell as evidenced by loss of NKG2D and CD69. In contrast,
another study showed that LPS-induced anergy does not involve
loss of CD69 by NKT cells and NKG2D expression was not
examined [15]. However to the best of our knowledge these
findings are the first to demonstrate that a bacterial exotoxin can
alter the activation potential of NKT cells and it seems the
mechanism is different from that employed by LPS.
NKT cells from toxin-treated mice are viable and
non-apoptotic
We assessed Annexin V versus 7-AAD (7-amino-actinomycin D)
staining in a-GC/CD1d tetramer
+/TCRb
+ NKT cells which
allows one to distinguish live, non-apoptotic cells (AnnV
2/7-
AAD
2) from early apoptotic (AnnV
+/7-AAD
2), late apoptotic
(AnnV
+/7-AAD
+) and necrotic (AnnV
2/7-AAD
+) cells (Figure 3,
left panels). We did not observe any changes in binding of Annexin
V or uptake of 7-AAD by NKT cells following toxin treatment.
We examined expression of the programmed-death-1 molecule
(PD-1) recently reported to be required for NKT anergy induction
[25]. LT treatment did not affect NKT expression of PD-1
(Figure 3, middle panels). We also assessed expression of Fas which
was not altered by treatment with the toxin (Figure 3, right panels).
This is in contrast to BCG which induces Fas up-regulation and
Anthrax Toxins Inhibit NKT Function
PLoS Pathogens | www.plospathogens.org 3 September 2009 | Volume 5 | Issue 9 | e1000588Figure 1. PA binds to NKT cells. Hepatic lymphocytes, splenocytes, lymph node cells and thymocytes were obtained from C57BL/6 mice. A Cells
were stained with a-GC-loaded PE-CD1d tetramer and FITC-anti-TCRb mAb to distinguish NKT cells, T cells and non-T/NKT cells. Samples were also
counter-stained with Alexa647-PA to detect PA-binding proteins. Histograms show PA binding to each cell type. B Splenocytes were stained as
described and with the concentrations of Alexa647-PA indicated. Graph shows effect of PA concentration on binding to different cell types. The
histogram shows the effect of unlabeled PA on binding of Alexa647-PA. Filled histogram=no PA, continuous line=Alexa647-PA, dotted
line=Alexa647-PA plus unlabeled PA. The data in A for spleen, lymph node and thymus are representative of three independent experiments.
Binding of PA to hepatocytes in A and the dose response curve in B are from a single experiment. C Cell lysates were prepared from whole
splenocytes (left lane) and hepatocytes (middle lane) of C57BL/6 mice (middle lane). NKT cells were enriched from the spleens of C57BL/6 mice and
expanded in vitro for 5 d until 96% pure (right lane). Cell lysates were resolved by SDS-PAGE and examined by immunoblotting for the anthrax toxin
receptors TEM-8 and CMG-2 and the anthrax toxin intracellular target MEK-2 which serves as a loading control.
doi:10.1371/journal.ppat.1000588.g001
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These results suggest that the sub-lethal dose of toxin administered
in our study does not result in cell death, apoptosis or PD-1-
dependent anergy in NKT cells and reinforces the concept that the
mechanisms of anergy induction by BCG, LPS, a-GC and LT are
different from each other.
It is possible that our method of gating on live lymphocytes by
FSC/SSC profile excludes cells that have been killed by LT. We
therefore gated on FSC
lo/SSC
hi cells and assessed the effect of
toxin on the number of ‘dead’ cells as well as the frequency of a-
GC/CD1d tetramer-binding cells and their Annexin V binding
and 7-AAD uptake (Figure S4). LT had very little effect on the
number of non-viable cells recovered but there was considerable
non-specific binding of tetramer to those dead cells. As expected
those cells were either AnnV
+/7-AAD
+ or AnnV
2/7-AAD
+ and
thus non-viable. Therefore while LT is likely to result in NKT
necrosis in vivo, those cells are likely cleared from the spleen and
live non-apoptotic cells are recovered in our assays.
LT inhibits CD1d/a-GC-stimulated cytokine production
LT induced an inactivated but not an apoptotic phenotype. We
therefore determined if prior toxin treatment affected TCR-
mediated NKT activation (Figure 4). We obtained splenocytes
from PBS- and LT-treated mice and stimulated them in vitro with
a-GC. We observed that LT-treated mice had a substantially
reduced production of IL-4 and IFNc following toxin treatment
(Figure 4A). While this experiment showed that LT treatment
reduced the ability of NKT cells to be activated by a-GC, it did not
determine whether the LT was acting on APCs in the mixed
splenocyte culture or the NKT cells or both. Published reports
show that DCs, macrophages, B cells and Th cells can all be
targeted by anthrax toxins [16,17,18,26], and thus it is conceivable
that the target of LT in these cultures is the APC. To address this
issue we separately exposed the NKT cells and the APCs (Ja18
2/2
splenocytes) to LT, washed the cells and then cultured them
separately or together with and without a-GC (Figure 4B). For this
approach we obtained splenocytes from Type I (a-GC-reactive)
NKT-deficient Ja18
2/2 mice and in vitro-expanded NKT cells
derived from C57BL/6 splenocytes. We treated Ja18
2/2
splenocytes and NKT cells with PBS or LT before washing and
then co-cultured the cells with or without a-GC (Figure 4B). We
observed that IL-4 production was not affected, but IFNc
production was inhibited when the NKT cells but not the
Ja18
2/2 splenocytes that were treated with LT. The reason for the
lack of inhibition of IL-4 production in Figure 4B is not clear, but
may be attributable to the behavior of the in vitro-expanded NKT
cells as compared to the whole C57BL/6 splenocyte cultures. It is
possible that the Th1/Th2 balance in ex vivo-expanded NKT cells
is more readily disrupted following toxin treatment than in NKT
cells in freshly harvested mixed splenocytes.
Figure 2. LT alters expression of selected NKT cell surface markers. C57BL/6 were treated with 100 mg of LT in PBS by the i.v. route or mock-
treated with PBS alone. After 96 h, splenocytes were obtained and incubated with FcR-blocking mAb 2.4G2 in the presence of a-GC/CD1d tetramer,
anti-TCRb mAb and mAbs as indicated. Cells were then washed, fixed and analyzed by flow cytometry. A Shows a-GC/CD1d tetramer
+/TCRb
+ NKT
cells B Histograms show expression of indicated markers after gating on NKT cells. Data are representative of 3 independent experiments.
doi:10.1371/journal.ppat.1000588.g002
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production required active LF (Figure 4C). Mice were treated in
vivo with PBS, the non-functional mutant PA+LF
H690C, or active
LT before enriching NKT cells and stimulating them in vitro with
anti-CD3 and CD28 mAbs. We observed that only the active toxin
was able to suppress cytokine production by the NKT cells. It
should be noted that the method used for NKT stimulation in
Figure 4C (CD3 and CD28 cross-linking rather than stimulation
with a-GC), may have resulted in activation of Type I (a-GC-
reactive) and Type II (a-GC-non-reactive) NKT cells. However,
flow cytometric analysis revealed that 80–88% of the NK1.1
+/
TCRb
+ cells in the NKT preparation were a-GC/CD1d
tetramer-binding and therefore Type I NKT cells. These data
therefore show by different methods of NKT isolation, culture and
stimulation, that LT has a direct effect on NKT function with
respect to cytokine production.
LT inhibits TCR signaling in NKT cells
The MAPKK enzyme MEK-2 is proteolytically cleaved at the
N-terminus by lethal factor that has gained entry to TEM-8- and
CMG-2-expressing cells [20]. Phosphorylation of Erk (extracellu-
lar signal-regulated protein kinase) downstream of MEK-2 is a
critical component of TCR-signaling-induced cytokine transcrip-
tion [27]. We therefore performed experiments to determine if the
lack of CD1d/a-GC-inducible cytokine was attributable to effects
on the MAP Kinase/Erk signaling pathway. Enriched splenic
NKT cells were treated with PBS or LT and then stimulated by
CD3 cross-linking before preparation of cell lysates. Immunoblot
analysis was conducted to examine the effect on MEK-2, and the
status of TCR-induced Erk phosphorylation (Figure 5A). We used
a mAb specific for the N-terminus of the MEK-2 protein which
should have a decreased abundance in LT-treated cells. We
observed that LT but not PA caused a loss of signal indicating N-
terminal cleavage by LT. When NKT cells were treated with LT
at three different doses, phosphorylation of Erk was diminished in
a dose-dependent manner.
We also treated C57BL/6 mice with LT or PBS in vivo and then
harvested splenocytes. NKT cells were isolated using a-GC-loaded
CD1d tetramers and analyzed by SDS-PAGE and immunoblot-
ting (Figure 5B). We observed that NKT cells recovered from LT-
treated mice had a much lower amount of MEK-2 N-terminus
than in NKT cells of PBS-treated mice. This demonstrates that LT
leads to cleavage of NKT MEK-2 in vivo. We repeated this
experiment, comparing the effects of PBS, the non-functional LT
mutant and the wild type LT (Figure 5C). Consistent with our data
in Figure 4, we observed that only the wild type LT resulted in
cleavage of NKT MEK-2 in vivo.
Discussion
We demonstrated for the first time that anthrax LT had adverse
effects on NKT cell function. The mechanism of action involved
cleavage of MEK-2 and reduced phosphorylation of Erk. This was
evidenced by reduced TCR-stimulated cytokine production.
Indeed, reduced MAP kinase activation including diminished
phosphorylation of Erk is evident in anergic Th cells [28,29],
potentially explaining why LT induces anergy-like unresponsive-
ness in NKT cells stimulated via the TCR. We observed that both
Figure 3. NKT cells from toxin-treated mice are viable and non-apoptotic. C57BL/6 were treated with 100 mg of LT in PBS by the i.v. route or
mock-treated with PBS alone. After 4 d, splenocytes were obtained and incubated with FcR-blocking mAb 2.4G2 in the presence of CD1d tetramer
and anti-TCRb mAb and mAb or reagents indicated. After washing and fixation, cells were analyzed by flow cytometry. Data are representative of 3
independent experiments and show uptake of 7-AAD and expression of Annexin V, PD-1 and Fas by a-GC/CD1d tetramer
+/TCRb
+ cells.
doi:10.1371/journal.ppat.1000588.g003
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inhibited to a greater extent when the TCR was directly engaged
by CD1d/a-GC. This is consistent with published findings that
there is a hierarchical requirement for TCR induced MAP kinase
signaling in transcription of IFNc and IL-4 genes by Th cells [30].
At present, it is not clear why we observe the clearest down-
regulation of NKG2D expression at 96 h post toxin treatment and
apparent recovery of expression by 14 d. Our data are likely
reflective of the complex interplay of several factors including
toxin delivery to NKT cells in secondary lymphoid organs; toxin
entry and MEK-2 cleavage, reduced NKG2D transcription,
degradation of existing NKG2D, the half life of LT in vivo, the
lifespan of NKT cells and the rate of emigration of new NKT cells
from the thymus during toxin-induced stress.
Although TCR-mediated activation of NKT cells was inhibited
by anthrax LT, our data suggested that functional anergy may not
be limited to TCR-stimulated responses. We observed a loss of
NKG2D expression by NKT cells following LT treatment. The
Figure 4. LT inhibits a-GC-stimulated cytokine production. A C57BL/6 mice were treated with 100 mg of LT in PBS by the i.v. route or mock-
treated with PBS alone. After 4 d, splenocytes were obtained and stimulated in vitro with a-GC at a final concentration of 50 ng/ml. Supernatants
were collected after a further 24 and 48 h and stored at 280uC. B Splenocytes from Ja18
2/2 mice and ex vivo-expanded NKT cells from C57BL/6 mice
were treated in vitro with LT at a final concentration of 1 mg/ml for 1 h before washing and culturing separately or together in the presence or
absence of a-GC as described in A. IL-4 and IFNc concentrations in the supernatants were then determined by Bio-Plex analysis. Data show mean
cytokine concentration for 3 mice per group 6SD. Asterisk indicates significant difference between cytokine concentration in un-treated control and
samples from LT-treated mice. C C57BL/6 mice were treated with PBS, non-functional LT mutant, or wild type LT before enrichment of NKT cells using
anti-NK1.1-based magnetic isolation. Cells were stimulated with anti-CD3 and CD28 mAbs and culture supernatants collected after 48 h.
doi:10.1371/journal.ppat.1000588.g004
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cells suggests that LT-treated NKT cells will be less responsive to
ligation of killer-activatory receptors. At present, the implication
for overall NKT function is not clear because information on the
role of ‘‘NK receptors’’ on NKT cells is limited. NKG2D
+ type II
NKT cells (CD1d-restricted, non-reactive to r-GC) mediate
damaging IFNc-dependent immune responses to hepatitis B virus
[31]. It is possible that the Type I NKT cells studied herein and
expressing NKG2D have similar functions, leading to release of
cytokines including IFNc. It is also suggested that NKG2D could
act as a TCR co-receptor and therefore be required for optimal
cytokine production stimulated by CD1d/a-GC complexes [32].
The mechanism by which NKG2D expression is down-regulated
is similarly unclear, but may be due to inhibition of the MAP
Kinase pathway. Cross-linking of NK cell NKG2D leads to Erk
phosphorylation and activation of MAP kinase-dependent cyto-
toxicity toward target cells [33]. It is possible that the MAP kinase
signaling pathway governs expression of NKG2D by NKT cells.
Further examination of this issue is warranted.
While anthrax LT can undoubtedly kill a proportion of a target
cell population, in several studies, live toxin-treated cells are
recovered and found to be functionally impaired [16,17,18]. This
was observed for NKT cells whereby live, anergic cells were
recovered that did not stain with Annexin V or with 7-AAD
indicating that they were neither apoptotic or necrotic. Similarly,
other indicators of apoptosis such as increased FAS expression
were not detected. Most interesting, though is the observation that
PD-1 was not increased on LT-treated NKT cells. PD-1 has been
shown in a series of recent papers [25,34,35,36] to be an important
mediator of NKT anergy, whereby PD-1 blockade can prevent
anergy or CD28 ligation can reverse the effects of a-GC-induced
anergy [25,36]. As indicated by our results, the anergy induced by
LPS, a-GC and by anthrax LT may all be different, indicating that
researchers will need to consider a broader array of NKT function
in ascribing ‘‘anergy’’ to the functional status of an NKT cell.
Our data demonstrate that NKT cells are potentially a more
significant target of the anthrax LT than other immune cell types
because they express higher amounts of the TEM-8 and CMG-2
receptors (Figure 1). However, these data do not reveal if NKT
cells are more significant targets during anthrax infection. We
have observed that NKT cells and CD4
+ T cells are similarly
susceptible to LT in vivo and in vitro using the assays described
Figure 5. LT inhibits TCR-mediated signaling in NKT cells. A NKT cells were enriched from C57BL/6 splenocytes. Cells were then in vitro treated
withPBS,PA (4 mg/ml) or LT(0.25 mg/mlof PAplus0.25 mg/mlof LF),or 1.0 mg/mlor 4 mg/mlof eachprotein,andthenstimulatedby cross-linking CD3.
Cell lysates were prepared and resolved by SDS-PAGE and transferred to nitrocellulose membrane before immunoblotting for MEK-2 N-terminus,
phospho-Erk, total Erk, and the GAPDH loading control. Left panels show un-stimulated versus stimulated controls. Right panels show samples where
CD3 was cross-linked. Two exposure times are indicated for phospho-Erk (short=10 s, long=90 s). B C57Bl/6 were treated with LT in vivo as described
in materials and methods before collecting splenocytes and using CD1d-tetramers in conjunction with magnetic beads to obtain highly purified NKT
cells. Lysates were prepared and subjected to SDS-PAGE and immunoblot analysis as indicated. C Experiment in B was repeated except that mice were
treated with PBS, non-functional LT mutant, or wild type LT and NKT cells were obtained using the anti-NK1.1 enrichment method.
doi:10.1371/journal.ppat.1000588.g005
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receptor on NKT cells as compared to CD4
+ T cells may only
determine susceptibility to LT when there are very low amounts of
LT at the earliest stages of infection. Alternatively, CD4
+ T cells
and NKT cells may both express great enough numbers of PA
receptors to allow MEK-2 cleavage sufficient to prevent TCR-
induced cytokine production in both cell types. Efforts are
underway to assess the relative impact of LT on NKT cells as
compared to other immune cell types. Regardless of whether
anthrax LT affects one immune cell type more than another the
sustained deleterious effects of toxins on B cells, DC, Th and NKT
cells is likely to suppress the initiation of the adaptive immune
response and reduce the ability of the host to clear the pathogen.
Further study will focus on the implications of an LT insult on
subsequent NKT adaptive immune responses to a pathogen
challenge.
Supporting Information
Figure S1 Effect of LT on splenic weight, cell count and NKT
frequency. C57BL/6 mice were treated with 100 mg of LT in PBS
by the i.v. route or mock-treated with PBS alone. (A) After 4 d,
spleens were obtained and weighed before isolation of splenocytes
which were then enumerated. (B) In a separate experiment,
splenocytes were incubated with FcR-blocking mAb 2.4G2 in the
presence of a-GC/CD1d tetramer and anti-TCRb mAb and
analyzed by flow cytometry.
Found at: doi:10.1371/journal.ppat.1000588.s001 (0.10 MB TIF)
Figure S2 Down regulation of NKG2D expression is NKT
specific and requires active toxin. (A) C57BL/6 and Ja18
2/2 mice
were treated with 100 mg of LT in PBS by the i.v. route or mock-
treated with PBS alone. After 4 d, splenocytes were obtained and
incubated with FcR-blocking mAb 2.4G2 in the presence of CD1d
tetramer, anti-TCRb and anti-NKG2D mAb (C57BL/6) or anti-
NK1.1, anti-TCRb and anti-NKG2D mAbs (Ja18
2/2). Cells were
then washed, fixed and analyzed by flow cytometry. (B) C57BL/6
mice were treated as in (A) except that LF
H690C inactive mutant
was administered. Data shows expression of NKG2D by CD1d
tetramer
+/TCRa
+ cells.
Found at: doi:10.1371/journal.ppat.1000588.s002 (0.10 MB TIF)
Figure S3 Effect of LT on NKT expression of NKG2D at early
and late time points. C57BL/6 mice were treated with 100 mgo f
LT in PBS by the i.v. route or mock-treated with PBS alone. After
times indicated (A) splenocytes (B) LN cells and (C) thymocytes
were obtained and incubated with FcR-blocking mAb 2.4G2 in
the presence of a-GC/CD1d tetramer, anti-TCRb mAb and anti-
NKG2D mAb. Cells were analyzed by flow cytometry.
Found at: doi:10.1371/journal.ppat.1000588.s003 (0.27 MB TIF)
Figure S4 LT has minimal effect on frequency and number of
non-viable NKT cells in isolated splenocyte samples. The same
samples described in Figure 3 were re-analyzed this time gating on
FSC
lo/SSC
hi cells (density plot, left panel) and then gating on all
a-GC/CD1d tetramer-binding cells (dot plot, middle panels)
followed by analysis of Annexin V and 7-AAD staining (dot plot,
right panels).
Found at: doi:10.1371/journal.ppat.1000588.s004 (0.17 MB TIF)
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